Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anakinra in Cerebral Haemorrhage to Target Secondary Injury from Neuroinflammation
2024-517230-17-00Phase 2Authorised
- Sponsor
- Radboud University Medical Center
- Start
- Oct 2024
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of anakinra in intracerebral hemorrhage (ICH), sponsored by Radboud University Medical Center. Primary endpoint: Oedema extension distance (OED) determined with MRI. Planned start Oct 2024; status: authorised.
02
Drugs
anakinra
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on 2024-517230-17-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-517230-17-00.